Yamamoto T - Search Results

1

Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.

D'Souza W, Alsaadi T, Montoya J, Carreño M, Di Bonaventura C, Mohanraj R, Yamamoto T, McMurray R, Shastri O, Villanueva V; PERMIT study group. D'Souza W, et al. Among authors: yamamoto t. Seizure. 2022 Aug;100:56-66. doi: 10.1016/j.seizure.2022.06.008. Epub 2022 Jun 15. Seizure. 2022. PMID: 35777333 Free article.

2

Clinical utility of vagus nerve stimulation for progressive myoclonic epilepsy.

Fujimoto A, Yamazoe T, Yokota T, Enoki H, Sasaki Y, Nishimura M, Yamamoto T. Fujimoto A, et al. Among authors: yamamoto t. Seizure. 2012 Dec;21(10):810-2. doi: 10.1016/j.seizure.2012.08.009. Epub 2012 Sep 19. Seizure. 2012. PMID: 22999567 Free article. No abstract available.

3

[Clinical efficacy of the novel antiepileptic agent levetiracetam: evaluation in patients with localization-related epilepsy].

Yamazoe T, Fujimoto A, Yamazaki M, Yokota T, Okanishi T, Uchiyama T, Ohashi T, Tanaka T, Enoki H, Yamamoto T. Yamazoe T, et al. Among authors: yamamoto t. Brain Nerve. 2012 Oct;64(10):1169-74. Brain Nerve. 2012. PMID: 23037607 Japanese.

4

[Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].

Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H. Yamamoto T, et al. Brain Nerve. 2014 Jan;66(1):59-69. Brain Nerve. 2014. PMID: 24371132 Japanese.

5

New-onset refractory status epilepticus treated with vagus nerve stimulation: A case report.

Yamazoe T, Okanishi T, Yamamoto A, Yamada T, Nishimura M, Fujimoto A, Enoki H, Yokota T, Sato K, Yamamoto T. Yamazoe T, et al. Among authors: yamamoto a, yamamoto t. Seizure. 2017 Apr;47:1-4. doi: 10.1016/j.seizure.2017.02.011. Epub 2017 Feb 24. Seizure. 2017. PMID: 28267658 Free article. No abstract available.

6

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM).

Husni RE, Ngo LY, Senokuchi H, Patten A, Hiramatsu H, Watanabe K, Yamamoto T. Husni RE, et al. Among authors: yamamoto t. Epilepsia Open. 2022 Mar;7(1):59-66. doi: 10.1002/epi4.12551. Epub 2021 Nov 19. Epilepsia Open. 2022. PMID: 34657389 Free PMC article. Clinical Trial.

7

[Management of epilepsy in patients with brain tumors].

Yamamoto T. Yamamoto T. No Shinkei Geka. 2013 Jun;41(6):473-9. No Shinkei Geka. 2013. PMID: 23732758 Review. Japanese. No abstract available.

8

Vagus nerve stimulation therapy: indications, programing, and outcomes.

Yamamoto T. Yamamoto T. Neurol Med Chir (Tokyo). 2015;55(5):407-15. doi: 10.2176/nmc.ra.2014-0405. Epub 2015 Apr 28. Neurol Med Chir (Tokyo). 2015. PMID: 25925759 Free PMC article. Review.

9

Successful corpus callosotomy for Doose syndrome.

Kanai S, Okanishi T, Nishimura M, Iijima K, Yokota T, Yamazoe T, Fujimoto A, Enoki H, Yamamoto T. Kanai S, et al. Among authors: yamamoto t. Brain Dev. 2017 Nov;39(10):882-885. doi: 10.1016/j.braindev.2017.06.001. Epub 2017 Jun 30. Brain Dev. 2017. PMID: 28673533

10

[(3)New Therapeutic Modalities using Seizure Detection Devices for Medically Refractory Epilepsy:AspireSR and the RNS System].

Yamamoto T, Inaji M, Maehara T, Kawai K, Doyle WK. Yamamoto T, et al. No Shinkei Geka. 2018 Mar;46(3):247-262. doi: 10.11477/mf.1436203711. No Shinkei Geka. 2018. PMID: 29567875 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,015 results

Search Page